These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19156709)

  • 1. Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
    Seo HJ; Jung YE; Woo YS; Jun TY; Chae JH; Bahk WM
    Hum Psychopharmacol; 2009 Mar; 24(2):135-43. PubMed ID: 19156709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIADH with multiple antidepressants in a geriatric patient.
    Blass DM; Pearson VE
    J Clin Psychiatry; 2000 Jun; 61(6):448-9. PubMed ID: 10901346
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual action antidepressants and some important considerations.
    Gupta RK; Tiller JW; Burrows GD
    Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Masand PS; Gupta S
    Ann Clin Psychiatry; 2002 Sep; 14(3):175-82. PubMed ID: 12585567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
    Jung YE; Jun TY; Kim KS; Bahk WM
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):437-43. PubMed ID: 21726494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.
    Gardner ME; Malone DC; Sey M; Babington MA
    J Am Med Dir Assoc; 2004; 5(2):101-6. PubMed ID: 14984621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
    Rubio G; San L; López-Muñoz F; Alamo C
    J Affect Disord; 2004 Jul; 81(1):67-72. PubMed ID: 15183602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
    Acharya T; Acharya S; Tringali S; Huang J
    Pharmacotherapy; 2013 Oct; 33(10):1053-61. PubMed ID: 23776095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G; Hansen RA; Carey TS; Lohr KN; Gaynes BN; Randolph LC
    Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two new antidepressants: mirtazapine and venlafaxine].
    Birkenhäger TK; Moleman P
    Ned Tijdschr Geneeskd; 1999 May; 143(18):934-7. PubMed ID: 10368708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine plus venlafaxine in treatment-resistant depression.
    Devarajan S; Dursun SM
    J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Love, humor and psychosis in an atypical depression].
    Sicot R
    Encephale; 2005 Oct; 31 Pt 2():S11-3. PubMed ID: 16673695
    [No Abstract]   [Full Text] [Related]  

  • 20. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.